<qa>  What is the primary purpose of this study?The primary purpose of this study is to determine the safety of injections prepared from donor blood cells fused to a patients own tumor cells which are then used to treat advanced Stage IV kidney cancer renal cell carcinoma or RCC. The study will also explore the effect the injections have on the size of the tumor and the response in the patients immune system following administration. 